Gene: MEGF11
Official Full Name: multiple EGF like domains 11provided by HGNC
Gene Summary: Predicted to be involved in homotypic cell-cell adhesion and retina layer formation. Predicted to be located in basolateral plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24851 | MEGF11 Knockout cell line (HCT 116) | Human | MEGF11 | 1:2~1:4 | Negative | Online Inquiry |
KO24852 | MEGF11 Knockout cell line (HEK293) | Human | MEGF11 | 1:3~1:6 | Negative | Online Inquiry |
MEGF11 Gene Knockout Cell Lines are engineered cellular models specifically designed to elucidate the functional role of the MEGF11 gene in various biological processes. By employing the CRISPR-Cas9 genome editing technology, these cell lines exhibit a targeted deletion of the MEGF11 gene, allowing researchers to investigate the downstream effects of its absence. The knockout approach facilitates detailed examinations of the gene's involvement in cellular mechanisms, such as cell adhesion, signaling pathways, and developmental processes, which can significantly enhance our understanding of its contribution to health and disease.
The primary function of MEGF11 gene knockout cell lines lies in their ability to serve as a powerful tool in both basic and applied research. These cell lines allow for the assessment of phenotype alterations when MEGF11 is disrupted, paving the way for studies on its implications in conditions like cancer, neurodegenerative diseases, and developmental disorders. In clinical settings, insights gleaned from these studies can lead to the identification of novel therapeutic targets and biomarkers, potentially speeding the development of new treatment strategies.
What sets MEGF11 Gene Knockout Cell Lines apart from other available models is their precise genomic modification combined with rigorous validation of gene knockout efficiency. This ensures reliability and reproducibility in experimental outcomes, qualities that are essential in the realm of scientific research. Additionally, the versatility of these cell lines makes them suitable for a myriad of applications, from drug screening to gene function assays, allowing researchers to tailor their investigations based on specific experimental needs.
Investing in MEGF11 Gene Knockout Cell Lines not only provides researchers and clinicians a cutting-edge tool for investigating gene function but also helps in advancing our collective understanding of complex biological systems. The access to such specialized cell lines can significantly enhance the quality and depth of research, ultimately contributing to scientific advancement and innovation in therapeutic development.
Our company prides itself on offering high-quality biological products, underpinned by extensive expertise in genetic engineering and cell line development. We are committed to supporting researchers with state-of-the-art tools that empower them to explore the intricacies of genetics and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.